Identifier: TFG:2516
Authors: Ruiz López, Noelia
Abstract:
In clinical practice it is frequent to find patients who receive treatments with benzodiazepines (BZD) of a longer duration from the one recommended, causing an unfavorable risk-benefit relationship. There are different strategies for withdrawing treatment with BZD, but it is unknown what the nurse's specific function is in controlling and monitoring the treatment of these drugs to combat insomnia and anxiety. Objectives. Analyze the degree of autonomy and the specific function performed by the primary care nurse in the control and follow-up of benzodiazepine treatment for insomnia and anxiety. Methods. A bibliographic review was carried out using the databases of Pubmed, Cinhal and Google Scholar. Results. After including the articles that matched the selection criteria, 25 articles were finally selected. The results were grouped into three main topics: Risk-benefit perception in the use of BZD, function and degree of autonomy of nurses in the control of treatment with BZD and mechanisms to control their treatment. Discussion. This review proposes the nursing staff as a key piece to control the inertia of overloading with BZD that is used excessively and causes serious health problems and bad practices in the healthcare system. Although inadequate consumption of BDZ affects different health areas, it is suggested that control of the prescription begins in primary care as it is the first access to the health system for people with insomnia and anxiety disorders. In our environment, we should promote the role of the nurse in the monitoring and control of the prescription of BDZ. Conclusion. The nurse is valued with sufficient autonomy, clinical judgment and professional recognition to carry out tasks of identification of poor consumption, initiation and implementation of strategies for withdrawal, detection of dependence and / or addiction, and pharmacological and non-pharmacological education useful to fight insomnia and anxiety.